Cat. No.: X22-05-ZQ128

Adriacin

Synonym: 25316-40-9; Doxorubicin hydrochloride; Doxorubicin HCl; (7S,9S)-7-[(2R,4S,5S,6S)-4-Amino-5-Hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride

  • MDL: MFCD00077757
  • CAS Number: 25316-40-9
  • Compound CID: 443939
Product Size
Price
$593.04
Quantity:
Add to Cart
Add to basket
Datasheet
MSDS
Properties
Description
Adriacin suppresses cancer cell proliferation by forming a complex with cancer cell DNA and inhibiting DNA and RNA synthetase reactions. It is usually used to improve symptoms of malignant lymphoma, lung cancer, gastrointestinal cancer, breast cancer, bladder tumor, or bone sarcoma. This product can be used in anticancer activity research.
Molecular Weight
579.98
Molecular Formula
C27H29NO11·HCl
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Stability
The product is stable for two years when stored at the recommended temperature.
Applications
Adriacin can be used in anticancer activity research.
Storage
Store at 4°C. Protect from light.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0